Douglas Swirsky - Sep 14, 2021 Form 4 Insider Report for Cellectar Biosciences, Inc. (CLRB)

Role
Director
Signature
/s/ Christina Blakley, attorney-in-fact for Douglas J. Swirsky
Stock symbol
CLRB
Transactions as of
Sep 14, 2021
Transactions value $
$26,000
Form type
4
Date filed
9/14/2021, 04:00 PM
Previous filing
Jul 2, 2021
Next filing
Aug 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLRB Common Stock Purchase $26K +25K $1.04 25K Sep 14, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.